Effects of hepatocyte growth factor-mediated activation of Dll4-Notch-Hey2 signaling pathway

被引:3
作者
Gao Yu-fang [1 ]
Ha Xiao-qin [1 ]
Lue Tong-de [1 ]
Han Juan-ping [1 ]
机构
[1] Lanzhou Gen Hosp, Ctr Med Expt, Lanzhou 730050, Gansu, Peoples R China
基金
中国国家自然科学基金;
关键词
hepatocyte growth factor; genetic transcription; cell migration; cell proliferation; IN-VITRO; TRANSCRIPTION FACTOR; TIP CELLS; ANGIOGENESIS; GENE; PROLIFERATION; ISCHEMIA; THERAPY; NOTCH1; ASSAYS;
D O I
10.3760/cma.j.issn.0366-6999.2011.01.023
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Hepatocyte growth factor (HGF) treats ischemic disease by promoting arteriogenesis, however, its mechanism of action is not known. The notch signaling pathway plays an important role in neovascularization. The relationship between the proliferation and migration ability of artery endothelial cells and the Dll4-Notch-Hey2 signaling pathway in the process of arteriogenesis was investigated as a mechanism of action of HGF. Methods Based on the prophase study cells and supernatant were harvested at the indicated time after human femoral artery endothelial cells (HFAECs) were infected with adenovirus-HGF (Ad-HGF) at 200 pfu/cell. Cells were analyzed for HGF expression and Notchl, Dll4 and Hey2 expression by ELISA and reverse transcription-PCR (RT-PCR). The changes in the proliferation and migration ability of HFAECs were observed by MU and Transwell migration experiments. Ad-GFP-infected HFAECs were used as control. Results Compared with the control group the Ad-HGF group's HGF expression was not increased with time, and the induction by HGF of Notchl, Dll4 and Hey2 gene transcription was not enhanced with an increase of HGF. The proliferation ability of Ad-HGF-transduced HFAECs was enhanced and their migration ability was also enhanced in the presence of HGF. Conclusions Through activating the Dll4-Notch-Hey2 signaling pathway, HGF indirectly promotes the proliferation and migration ability of cells, so that offspring artery branches are formed. Chin Med J 2011;124(1):127-131
引用
收藏
页码:127 / 131
页数:5
相关论文
共 21 条
  • [1] Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, ets
    Aoki, M
    Morishita, R
    Taniyama, Y
    Kida, I
    Moriguchi, A
    Matsumoto, K
    Nakamura, T
    Kaneda, Y
    Higaki, J
    Ogihara, T
    [J]. GENE THERAPY, 2000, 7 (05) : 417 - 427
  • [2] A central role for hepatocyte growth factor in adipose tissue angiogenesis
    Bell, Lauren N.
    Cai, Liying
    Johnstone, Brian H.
    Traktuev, Dmitry O.
    March, Keith L.
    Considine, Robert V.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2008, 294 (02): : E336 - E344
  • [3] Suppression of hepatocyte growth factor production impairs the ability of adipose-derived stem cells to promote ischemic tissue revascularization
    Cai, Liying
    Johnstone, Brian H.
    Cook, Todd G.
    Liang, Zhong
    Traktuev, Dmitry
    Cornetta, Kenneth
    Ingram, David A.
    Rosen, Elliot D.
    Marcha, Keith L.
    [J]. STEM CELLS, 2007, 25 (12) : 3234 - 3243
  • [4] Promoting angiogenesis via manipulation of VEGF responsiveness with notch signaling
    Cao, Lan
    Arany, Praveen R.
    Wang, Yuan-Shuo
    Mooney, David J.
    [J]. BIOMATERIALS, 2009, 30 (25) : 4085 - 4093
  • [5] Mechanisms of Vessel Branching Filopodia on Endothelial Tip Cells Lead the Way
    De Smet, Frederik
    Segura, Inmaculada
    De Bock, Katrien
    Hohensinner, Philipp J.
    Carmeliet, Peter
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (05) : 639 - 649
  • [6] Hypoxia-mediated activation of Dll4-Notch-Hey2 signaling in endothelial progenitor cells and adoption of arterial cell fate
    Diez, Holger
    Fischer, Andreas
    Winkler, Anja
    Hu, Cheng-Jun
    Hatzopoulos, Antonis K.
    Breier, Georg
    Gessler, Manfred
    [J]. EXPERIMENTAL CELL RESEARCH, 2007, 313 (01) : 1 - 9
  • [7] Eccles Suzanne A., 2009, V467, P159, DOI 10.1007/978-1-59745-241-0_9
  • [8] Hepatocyte growth factor and granulocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy
    Guo, Ying-Hua
    He, Jian-Guo
    Wu, Jun-Lou
    Yang, Long
    Zhang, Dong-Sheng
    Tan, Xiao-Yan
    Qi, Rui-Dong
    [J]. CYTOTHERAPY, 2008, 10 (08) : 857 - 867
  • [9] Ha XQ, 2003, CHINESE MED J-PEKING, V116, P1029
  • [10] Gene therapy for pathological scar with hepatocyte growth factor mediated by recombinant adenovirus vector
    Xiaoqin Ha
    Bin Yuan
    Yuanmin Li
    Miaofen Lao
    Zuze Wu
    [J]. Science in China Series C: Life Sciences, 2003, 46 (3): : 320 - 327